Meanwhile, previous studies have shown that the expression of NER protein (ERCC1, ERCC2) may be sensitive prognostic indicators of radiochemotherapy for locally advanced HNSCC (52–54). Here, ERCC2 is linked to head and neck squamous cell carcinoma.